efaroxan has been researched along with propranolol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kleven, MS; Koek, W | 1 |
| Asrican, B; Lewey, J; Lisman, JE; Otmakhova, NA | 1 |
| Fagerholm, V; Haaparanta, M; Scheinin, M | 1 |
3 other study(ies) available for efaroxan and propranolol
| Article | Year |
|---|---|
Discriminative stimulus properties of cocaine: enhancement by beta-adrenergic receptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Benzofurans; Betaxolol; Brimonidine Tartrate; Cocaine; Discrimination Learning; Discrimination, Psychological; Drug Synergism; Imidazoles; Male; Nadolol; Narcotics; Propanolamines; Propranolol; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Thiophenes | 1997 |
Inhibition of perforant path input to the CA1 region by serotonin and noradrenaline.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Benzofurans; Dopamine; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; Imidazoles; In Vitro Techniques; Neural Inhibition; Neurons; Norepinephrine; Patch-Clamp Techniques; Perforant Pathway; Propranolol; Rats; Rats, Long-Evans; Serotonin; Serotonin Agents; Yohimbine | 2005 |
alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atropine Derivatives; Benzofurans; Blood Glucose; Drug Synergism; Fasting; Glyburide; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Secretion; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscarinic Antagonists; Naphthyridines; Phentolamine; Propranolol; Receptors, Adrenergic, alpha-2 | 2008 |